Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 10/20 | 0.52 |
| ▸ | LTA4H | P09960 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.33 |
| ▸ | FKBP5 | Q13451 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16616948 | 1.00 | TLR7 (0.52) | TLR7LTA4HHRH3KDM4EALDH1A1 | |
| SCHEMBL16624353 | 0.94 | TLR7 (0.44) | TLR7LTA4HHRH3 | |
| SCHEMBL16617042 | 0.88 | TLR7 (0.49) | TLR7KDM4EALDH1A1 | |
| SCHEMBL16617043 | 0.88 | TLR7 (0.49) | TLR7KDM4EALDH1A1 | |
| SCHEMBL15393452 | 0.86 | TLR7 (0.48) | TLR7HRH3 | |
| SCHEMBL16617074 | 0.81 | TLR7 (0.45) | TLR7 | |
| SCHEMBL853422 | 0.79 | TLR7 (0.38) | TLR7 | |
| SCHEMBL15391165 | 0.79 | TLR7 (0.59) | TLR7KDM4E | |
| SCHEMBL16616829 | 0.78 | TLR7 (0.39) | TLR7 | |
| SCHEMBL16616745 | 0.78 | TLR7 (0.85) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12077510-B2 | Carboxylic acid compounds | Sumitomo Pharma Co., Ltd. (JP) | 2024-09-03 | — | — | US | disclosed |
| US-20220267282-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-08-25 | — | — | US | disclosed |
| US-11299465-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2022-04-12 | — | — | US | disclosed |
| US-20200317623-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2020-10-08 | — | — | US | disclosed |
| US-10562861-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2020-02-18 | — | — | US | disclosed |
| US-20190119220-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2019-04-25 | — | — | US | disclosed |
| US-10150743-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2018-12-11 | — | — | US | disclosed |
| US-20160251319-A1 | CARBOXYLIC ACID COMPOUNDS | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2016-09-01 | — | — | US | disclosed |
| US-9376398-B2 | Carboxylic acid compounds | SUMITOMO DAINIPPON PHARMA CO., LTD (JP) | 2016-06-28 | — | — | US | disclosed |
| US-20150099770-A1 | CARBOXYLIC ACID COMPOUNDS | Sumitomo Pharma Co., Ltd. (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099770-A1 | CARBOXYLIC ACID COMPOUNDS | C9, SUCNR1, C3AR1 | TLR7 87/4885LTA4H 597/4885HRH3 19/4885 |
| US-20160251319-A1 | CARBOXYLIC ACID COMPOUNDS | C9, SUCNR1, C3AR1 | TLR7 87/4885LTA4H 597/4885HRH3 19/4885 |
| US-10150743-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
| US-12077510-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
| US-20200317623-A1 | CARBOXYLIC ACID COMPOUNDS | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
| US-20190119220-A1 | CARBOXYLIC ACID COMPOUNDS | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
| US-11299465-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
| US-20220267282-A1 | CARBOXYLIC ACID COMPOUNDS | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
| US-10562861-B2 | Carboxylic acid compounds | C9, C3AR1, SUCNR1 | TLR7 79/4885LTA4H 760/4885HRH3 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.